2014 - World Transplant Congress
This page contains exclusive content for the member of the following sections: TTS. Log in to view.
Pre-Meeting - Clinical Transplant Update
122.24 - Diverting into the Pipeline - How Do We Best Develop Drugs From Other Disease States for Transplantation? (e.g., campath, ritu1an, bortezimab,etc.) Need for Proper Transplant Trials
Presenter: Allan, Kirk, Durham, United States
Authors: Allan Kirk
By viewing the material on this site you understand and
- The opinions and statements expressed on this site reflect the
views of the author or authors and do not necessarily reflect those of
The Transplantation Society and/or its Sections.
- The hosting of material on The Transplantation Society site does
not signify endorsement of this material by The Transplantation Society
and/or its Sections.
- The material is solely for educational purposes for qualified
health care professionals.
- The Transplantation Society and/or its Sections are not liable for
any decision made or action taken based on the information contained in
the material on this site.
- The information cannot be used as a substitute for professional
- The information does not represent a standard of care.
- No physician-patient relationship is being established.